Stage IV Esophageal Squamous Cell Carcinoma
Information
- Disease name
- Stage IV Esophageal Squamous Cell Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01178944 | Completed | Phase 2 | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer | September 2010 | November 2015 |
| NCT04221893 | Recruiting | N/A | Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers | August 7, 2020 | November 30, 2026 |
| NCT02011594 | Withdrawn | Phase 2 | Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma | January 2014 | February 2015 |
| NCT02034968 | Withdrawn | Phase 2 | Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma | February 2014 | January 2017 |